JHLT Open – Journal – Elsevier
An Official Publication of the International Society for Heart and Lung Transplantation, JHLT Open brings readers essential scholarly and timely information i…
Related Articles
JHLT: The Podcast: Episode 42: May 2024
On this episode of JHLT: The Podcast, the JHLT Digital Media Editors explore two studies from the May issue of The Journal of Heart and…
Acute T cell leukemia in a stable recipient of a heart transplantation
Adult T-cell leukemia/lymphoma (ATLL) is a rare disease caused by the human T-lymphotropic virus (HTLV). Only 4% of patients infected with HTLV contract ATLL, and…
Does pulmonary endarterectomy improve the clinical conditions of patients with chronic thromboembolic pulmonary disease without pulmonary hypertension?
To verify whether the new hemodynamic definition of pulmonary hypertension (PH) has any implication in treatment of Chronic Thrombo-Embolic Pulmonary Disease (CTEPD) patients without PH, we…
Blockade of BLyS inhibits B-cell responses and antibody production for the prevention of chronic transplant rejection
Chronic rejection, closely related to the activation of B cells and donor-specific antibody (DSA) production, has unsatisfactory therapeutic outcomes. B lymphocyte stimulator (BLyS) is a…
Acute right ventricular geometric change predicts outcomes in HeartMate 3 patients
The physiological response of the right ventricle (RV) following left ventricular assist device (LVAD) implantation is difficult to predict. We aimed to investigate RV geometric…
Development and validation of primary graft dysfunction predictive algorithm for lung transplant candidates
Primary graft dysfunction (PGD) is the leading cause of early morbidity and mortality after lung transplantation. Accurate prediction of PGD risk could inform donor approaches…
A multicenter evaluation of the HeartMate 3 risk score
The Heartmate 3 (HM3) risk score (HM3RS) was derived and validated internally from within the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory…
Impact of recipient age on mortality among Cytomegalovirus (CMV)-seronegative lung transplant recipients with CMV-seropositive donors
Cytomegalovirus (CMV)-seronegative lung transplant recipients (LTRs) with seropositive donors (CMV D+/R−) have the highest mortality of all CMV serostatuses. Due to immunosenescence and other factors,…